Fibrosis Biomarkers clinical trials

Nottingham Community Liver Biomarkers Cohort

This study in Nottingham looks at improving how we find liver disease early in the community. It involves people with risk factors like heavy alcohol use, obesity, or diabetes, to see if new blood and scan tests can help identify liver problems before they become serious.